Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: Long-Term Follow-Up

Lignende værker

• Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: A Preliminary 20-Week, Open-Label Study
  af: Heller, James H., et al.
  Udgivet: (2006)
• Donepezil Effects on Language in Children With Down Syndrome: Results of the First 22-Week Pilot Clinical Trial
  af: Heller, James H., et al.
  Udgivet: (2004)
• Donepezil for the Treatment of Language Deficits in Adults With Down Syndrome: A Preliminary 24-Week Open Trial
  af: Heller, James H., et al.
  Udgivet: (2003)
• Prevalence of Iron Deficiency in Children with Down Syndrome
  af: Dixon, Natalia E, et al.
  Udgivet: (2010)
• Hypothyroidism in Down Syndrome: Screening Guidelines and Testing Methodology
  af: Hardy, Olga, et al.
  Udgivet: (2004)